tiprankstipranks
Advertisement
Advertisement

XNCR Stock Latest News

Xencor Advances Dual-Antibody Cancer Trial, Keeping Investor Focus on XNCR
Company AnnouncementsXencor Advances Dual-Antibody Cancer Trial, Keeping Investor Focus on XNCR
3d ago
XNCR
Analyst John Newman Reiterates Buy on Xencor, Citing Late-Stage XmAb Pipeline, Non-Dilutive Cash Inflows and Royalties, and Sets $38 Price Target
PremiumRatings
Analyst John Newman Reiterates Buy on Xencor, Citing Late-Stage XmAb Pipeline, Non-Dilutive Cash Inflows and Royalties, and Sets $38 Price Target
10d ago
XNCR
Xencor price target raised to $30 from $26 at Wedbush
PremiumThe Fly
Xencor price target raised to $30 from $26 at Wedbush
10d ago
XNCR
Xencor price target raised to $44 from $43 at Cantor Fitzgerald
PremiumThe Fly
Xencor price target raised to $44 from $43 at Cantor Fitzgerald
10d ago
XNCR
Xencor price target raised to $20 from $19 at RBC Capital
PremiumThe Fly
Xencor price target raised to $20 from $19 at RBC Capital
10d ago
XNCR
Xencor: Buy Rating Backed by XmAb819 Expansion and Immunology Pipeline Milestones Ahead of Key 2026–2027 Data Catalysts
PremiumRatingsXencor: Buy Rating Backed by XmAb819 Expansion and Immunology Pipeline Milestones Ahead of Key 2026–2027 Data Catalysts
10d ago
XNCR
Xencor Earns Buy Rating as XmAb541 and XmAb808 Advance Toward Differentiated Solid-Tumor Franchise
Premium
Ratings
Xencor Earns Buy Rating as XmAb541 and XmAb808 Advance Toward Differentiated Solid-Tumor Franchise
10d ago
XNCR
Xencor reports Q2 EPS (29c), consensus (84c)
Premium
The Fly
Xencor reports Q2 EPS (29c), consensus (84c)
11d ago
XNCR
Xencor participates in a conference call with Cantor
PremiumThe Fly
Xencor participates in a conference call with Cantor
13d ago
XNCR
Xencor’s XmAb412 Enters First-in-Human Testing: What Early-Stage Investors Should Watch
PremiumCompany Announcements
Xencor’s XmAb412 Enters First-in-Human Testing: What Early-Stage Investors Should Watch
13d ago
XNCR
Xencor Expands Plamotamab Into Rheumatoid Arthritis: What Early Trial Progress Means for Investors
PremiumCompany Announcements
Xencor Expands Plamotamab Into Rheumatoid Arthritis: What Early Trial Progress Means for Investors
13d ago
XNCR
Xencor Inc. (XNCR) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Xencor Inc. (XNCR) Q2 Earnings Cheat Sheet
13d ago
XNCR
Xencor Secures Ultomiris Royalty Settlement Payment
PremiumCompany AnnouncementsXencor Secures Ultomiris Royalty Settlement Payment
18d ago
8K
XNCR
Xencor to receive $105M from Alexion to resolve Ultomiris royalty matter
Premium
The Fly
Xencor to receive $105M from Alexion to resolve Ultomiris royalty matter
18d ago
XNCR
Xencor price target lowered to $27 from $29 at Truist
Premium
The Fly
Xencor price target lowered to $27 from $29 at Truist
1M ago
XNCR
Xencor Shareholders Approve Directors, Incentive Plan Amendments
PremiumCompany Announcements
Xencor Shareholders Approve Directors, Incentive Plan Amendments
2M ago
8K
XNCR
Acting FDA head vows to block political interference, Endpoint News says
PremiumThe Fly
Acting FDA head vows to block political interference, Endpoint News says
2M ago
AZN
BMY
FDA issues draft guidance to help accelerated cell, gene therapies for patients
PremiumThe Fly
FDA issues draft guidance to help accelerated cell, gene therapies for patients
2M ago
AZN
BMY
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
PremiumThe Fly
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
3M ago
AZN
BMY
Trump Trade: U.S. plans AI security order without required model tests
PremiumThe FlyTrump Trade: U.S. plans AI security order without required model tests
3M ago
DYN
RNA
Trump approves plan to fire FDA head Marty Makary, CBS reports
Premium
The Fly
Trump approves plan to fire FDA head Marty Makary, CBS reports
3M ago
DYN
RNA
Xencor price target raised to $14 from $13 at JPMorgan
Premium
The Fly
Xencor price target raised to $14 from $13 at JPMorgan
3M ago
XNCR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >